dc.contributor.author
Beça, Sara
dc.contributor.author
Alba Garibay, Marco Antonio
dc.contributor.author
Hernández Rodríguez, José
dc.contributor.author
Espigol Frigolé, Georgina
dc.contributor.author
Prieto González, Sergio
dc.contributor.author
Cid Xutglà, M. Cinta
dc.contributor.author
Baños, Núria
dc.contributor.author
Espinosa Garriga, Gerard
dc.date.issued
2024-12-02T13:00:00Z
dc.date.issued
2025-02-21T06:10:21Z
dc.date.issued
2024-06-01
dc.date.issued
2024-11-21T16:31:18Z
dc.identifier
https://hdl.handle.net/2445/216866
dc.description.abstract
Objectives: To analyze pregnancy outcomes of patients with primary systemic vasculitis followed in a third-level referral center. Methods: Retrospective cohort study of all pregnant women with systemic vasculitis followed between 2009 and 2022 at the High-Risk Pregnancy Clinic of the Department of Systemic Autoimmune Diseases of the Hospital Clinic, Barcelona. Results: Twenty women with primary vasculitis were identified, with a total of 30 pregnancies. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (n = 7) and Behcet disease (n = 4) were the most frequent types of vasculitis. All women had the diagnosis of vasculitis before pregnancy, with a median time between disease diagnosis and pregnancy of 5.8 years (range: 2 months-29 years). Most were in remission at conception (76.7 %). During pregnancy, a vasculitis flare occurred in 4 (13.3 %) patients (one each with Takayasu arteritis, eosinophilic granulomatosis with polyangiitis [EGPA], IgA vasculitis [IgAV], and Behcet disease [BD]). Four (16.7 %) of the successful pregnancies had post-partum relapses (one each with EGPA, granulomatosis with polyangiitis, IgAV, and BD). Eighty percent of pregnancies resulted in live babies. In four cases (13.3 %), medical termination of pregnancy was decided, considering the mother or baby health risk. There were two spontaneous miscarriages, and no stillbirths or neonatal deaths. Preeclampsia was the most frequent maternal complication (25 %). Newborns were preterm in 24 % and low birthweight in 20 % of cases. No maternal deaths occurred. Conclusions: This cohort study shows that vasculitis relapses during pregnancy and post-partum, together with other pregnancy complications, occur in a considerable number of patients with systemic vasculitides, although a final good pregnancy outcome can be expected in most cases. These findings emphasize the convenience of managing these special situations in expert reference centers.
dc.format
application/pdf
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.semarthrit.2024.152412
dc.relation
Seminars In Arthritis And Rheumatism, 2024, vol. 66
dc.relation
https://doi.org/10.1016/j.semarthrit.2024.152412
dc.rights
cc-by-nc-nd (c) Elsevier, 2024
dc.rights
http://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject
Malaltia de Behçet
dc.subject
Behçet's disease
dc.title
Maternal and fetal outcomes of pregnancy in women with primary systemic vasculitis: A single-center cohort study of 20 patients and 30 pregnancies
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion